Trial intelligence / Profile preview

BCG vaccination to reduce absenteeism in healthcare workers during the COVID-19 pandemic

2020-000919-69Phase 4Completed

Sponsor
University Medical Center of Southern Nevada
Start
Mar 2020
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing BCG vaccination with Placebo / no BCG (2 arms). Primary endpoint: Number of days of unplanned absenteeism for any reason. Started Mar 2020; status: completed.

02

Drugs

bcg vaccine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on 2020-000919-69.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-000919-69.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call